PR98570

HSINCHU, Nov. 1, 2022 /PRNewswire=KYODO JBN/ --

ICP DAS - BMP (Biomedical Polymers), a Taiwan medical TPU (thermoplastic

polyurethane) supplier, will exhibit TPU pellets with 50% tungsten content

(W50) for the first time in the COMPAMED 2022, Germany. The exhibition - a

melting pot for high-tech solutions in the medical technology sector - takes

place in DÜSSELDORF from 14 to 17 November.

ICP DAS - BMP will showcase three series of highly stable medical-grade TPU

pellets, namely, Alithane(TM) (ALP series), Durathane(TM) (ALC series), and

Arothane(TM) (ARP series). This year, ICP DAS - BMP unveils a new range of

pellets with a tungsten content of 30% (W30) and 50% (W50), respectively. As we

advance, ICP DAS - BMP plans to develop pellets with 70% tungsten content (W70)

and a new ARP-CHDM series in 2023.

All medical-grade TPU pellets by ICP DAS - BMP are 100% made in Taiwan and have

superb biocompatibility, hydrolytic & chemical resistance, mechanical

properties, and radiodensity; they can be customized and color-matched. To

provide customers with the best service, ICP DAS - BMP offers shorter lead

times and accepts smaller quantity orders.

Applications of medical-grade TPU pellets range from cancer treatment and

urology devices to retainers, etc. Shortly after being established, ICP DAS -

BMP achieves outstanding results domestically and internationally. Medical

device manufacturers from South Korea, Israel, and France have chosen ICP DAS -

BMP's trustworthy and high-quality TPUs.

Visit ICP DAS - BMP's booth at Hall 08B, Booth 8BC17-2, from 14 to 17 November

2022, and learn more about the upcoming ARP-CHDM series.

About ICP DAS - BMP

In response to the growing demand for TPUs in medical applications, in 2018,

ICP DAS established a new business unit to develop and produce medical-grade

TPUs, ICP DAS - BMP. The company has obtained ISO 13485 certification for its

raw material warehouses and production lines.

ICP DAS - BMP has its own laboratories for polymerization, physical properties

analysis, and cytotoxicity testing. All the TPUs supplied by ICP DAS - BMP are

USP Class VI certified and compliant with the ISO 10993 international standard.

Materials have passed skin sensitization and cytotoxicity tests according to

ISO 10993-5 and ISO 10993-10. These enable ICP DAS - BMP to guarantee

biocompatibility for medical device manufacturers.

For more details, please visit our website: https://bmp.icpdas.com/

For TPU products, solutions, and inquiries, contact us directly:

sales_bmp@icpdas.com

Source: ICP DAS Co., Ltd.

Image Attachments Links:

   Link: http://asianetnews.net/view-attachment?attach-id=432804

   Caption: ICP DAS - BMP to partake in the COMPAMED 2022, Germany